Nontuberculous mycobacterial lung disease study in South China
Part of Infections clinical trials.
This study will look at people with a lung infection called nontuberculous mycobacterial lung disease to find out more about how their immune system reacts. If you have this condition, your medical history and possibly a lung sample can help researchers understand why some people get sicker than others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a lung infection caused by nontuberculous mycobacteria (germs found in water or soil).
- You are 18 years old or older.
- You have medical records from between 2015 and 2025 (for the part of the study looking back at past cases).
- If you join the part that looks forward, you must be willing to give a sample from your lungs (bronchoscopy) and be stable enough for the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the DNA of the bacteria causing your lung infection (Mycobacterium avium) to understand treatment better. It involves analyzing stored samples and may include patients who have been treated before.
This study checks whether a blood test called soluble programmed death-1 can help predict how nodular-bronchiectatic nontuberculous mycobacterial (NTM) lung disease will progress. Results may help doctors monitor patients more accurately and decide when to treat or follow more closely.
This study looks at how nutrition and immune cell activity relate to the progression of lung disease caused by nontuberculous mycobacteria (NTM). It may help doctors better understand and monitor this chronic infection.
This trial tests whether inhaled hypertonic saline can improve symptoms and lung health in people with a specific lung infection called MAC. It targets adults with confirmed MAC infection and bronchiectasis who are not already on certain MAC medications.
This trial studies whether inhaling hypertonic (very salty) saline helps treat nodular-bronchiectatic lung disease caused by Mycobacterium avium complex (MAC). It may help reduce ongoing infection and symptoms if you have the right type of MAC lung pattern and have not recently started the usual MAC treatments.
This study follows people with a newly diagnosed MAC lung infection (a specific type of mycobacterial disease) and tests how they do on the standard three-drug treatment plan. It may help researchers better understand outcomes and safety for this condition.
Hear when a new Nontuberculous Mycobacterial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.